Mr. Ronald A. Rader has been President of his own publishing/consulting company, the Biotechnology Information Institute, since late 1990. Mr. Rader has a B.S. (Microbiology), M.L.S. (Library/Information Science), and 30 years experience as a biotechnology and pharmaceutical information specialist, author, publisher and consultant. He is a world-class expert in biotechnology and pharmaceutical information, particularly competitive intelligence, technology and market assessments, and information resources development. [See his full Resume].
Mr. Rader is best known as the author and publisher of BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets, the only reference/information resource concerning biopharmaceuticals (now an online Web database; last printed book version, 6th edition, 2 vol., 1602 pages, Sept. 2007). He also r recently authored Biopharmaceutical Expression Systems and Genetic Engineering Technologies: Current and Future Manufacturing Platforms (365 pages, Oct. 2008). For 15 years, from 1988-early 2003, he was author and publisher of the Antiviral Agents Bulletin, the only periodical specializing in antiviral/HIV drug and vaccine development. In 1994, he published the Federal Bio-Technology Transfer Directory, a 678-page book abstracting and indexing all federal, e.g., NIH, inventions and technology transfers in biotech/biomedical areas, further marketed as an online database until 2000.
From 1985-1990, Mr. Rader was Manager of Information Services, Porton International plc, providing information and competitive intelligence services and market/technology analyses for what was then the world's largest privately-held biotechnology company. Prior to that he served as a biomedical/chemical information specialist/manager/analyst with companies including Gillette Medical Evaluation Labs., Gillette Co.; MITRE Corp.; Biospherics; Computer Sciences Corp. (CSC); Technical Resources Inc.; and Bio-Conversion Labs.
Recent periodical articles include:
- "(Re)defining Biopharmaceutical" Nature Biotechnology, July 2008, 26(7), p. 743-751.
- "Expression Systems for Process and Product Development: A Perspective on Opportunities for Innovator and Follow-on Product Developers," BioProcess International, vol. 6, issue 6, suppl. 4, Success Stories in Protein Expression, p. 4-9, June 2008 [supplement lead article].
- "Biopharmaceuticals: Lack of Information Disclosure Confounds Public Trust, Particularly in the Context of Biosimilars," BioWorld Perspectives, vol. 2, issue 18, May 1, 2008.
- "Paucity of Biopharma Approvals Raises Alarm: Lower Numbers, Novelty and Economic Impact Indicate Problems," Genetic Engineering & Biotechnology News (GEN), March 15, 2008
- "How Big is the World Market for Biopharmaceuticals? It All Depends How You Define Biopharmaceutical," in Friedman, Y., Best Practices in Biotechnology Business Development, Logo Press, p. 175-85, 2008.
- "What Is a Generic Biopharmaceutical? Biogeneric? Follow-On Protein? Biosimilar? Follow-On Biologic?" Part 1: Introduction and Basic Paradigms - BioProcess International, March 2007.
- "What Is a Generic Biopharmaceutical? Biogeneric? Follow-On Protein? Biosimilar? Follow-On Biologic?" Part 2: Information, Nomenclature, Perceptions, and the Market - BioProcess International, May 2007.
- Biopharmaceutical Approvals Review - Genetic Engineering News, Aug. 1, 2006
-
What is a Biopharmaceutical, Part 1: (Bio)Technology-Based Definitions - BioExecutive, March 2005.
- What is a Biopharmaceutical, Part 2: Company and Industry Definitions - BioExecutive, May 2005.
Mr. Rader's main Web sites:
Earlier books, periodicals and studies authored by Mr. Rader include:
- BioINVENTION, a U.S. biotechnology patent abstract and news periodical; Editor, 1985-1990
- Federal Biotechnology Information Resources Directory; lead author/editor
- Federal Biotechnology Programs Directory; lead author/editor
- Survey of Compounds Which Have Been Tested for Carcinogenic Activity [Chemical Editor]
- "Analysis of U.S. Biotechnology Patents," issued annually, 1986-1988, by the Pharmaceutical Manufacturers Association (PMA, now PhRMA).
- Chemical Information Resources Directory, 673 pages
Further information: Resume
